Intermittent androgen suppression in prostate cancer: the Canadian experience
- 1 September 2002
- Vol. 60 (3) , 52-56
- https://doi.org/10.1016/s0090-4295(02)01572-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Intermittent androgen suppression in the management of prostate cancerUrology, 1999
- Osteoporosis After Orchiectomy for Prostate CancerJournal of Urology, 1997
- Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinomaCancer, 1997
- Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinomaThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour modelThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Intermittent androgen suppression in the treatment of prostate cancer: A preliminary reportUrology, 1995
- Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancerCancer, 1993
- Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigenCancer, 1993
- Experimental Treatment of Prostatic Cancer by Intermittent Hormonal TherapyJournal of Urology, 1987
- Intermittent endocrine therapy for advanced prostate cancerCancer, 1986